Literature DB >> 2415196

The isolated stomach preparation of the mouse: a physiological unit for pharmacological analysis.

J W Black, N P Shankley.   

Abstract

Although oxyntic cell secretion can be studied at many organisation levels between isolated cell suspensions and non-invasive techniques in animals, the isolated, lumen-perfused, stomach preparation of the mouse represents a hierarchical level which eliminates extrinsic regulatory influences but retains all the cellular architecture known to be necessary for physiological responses and so can be defined as the physiological unit of acid secretion. The feeding pattern before and the distending pressure during an experiment have been identified as the main determinants of basal secretion: the combination of an intragastric pressure of 12 cmH2O and the fasted state generated a stable basal secretion over 2 h providing a satisfactory basis for bioassays. Basal acid secretion was lowered by treatment with omeprazole and sodium thiocyanate but not with tetrodotoxin, N-methylatropine or tiotidine, suggesting that basal secretion does not involve nervous stimulation or the local release of histamine under these experimental conditions. The improved assay permitted the full characterization of cumulative agonist concentration-effect curves in single stomach preparations to histamine, 5-methylfurmethide, pentagastrin and isobutyl-methylxanthine. Interestingly, pentagastrin produced sustained stimulation of gastric acid secretion under conditions when there was no pharmacological evidence that histamine secretion was taking place. This finding is discussed in relation to the role of histamine in the control of gastric acid secretion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415196      PMCID: PMC1916718          DOI: 10.1111/j.1476-5381.1985.tb08933.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Conditions affecting acid secretion by mouse stomachs in vitro.

Authors:  H W DAVENPORT; V J CHAVRE
Journal:  Gastroenterology       Date:  1950-07       Impact factor: 22.682

Review 2.  Histamine: entering physiology.

Authors:  G Kahlson; E Rosengren
Journal:  Experientia       Date:  1972-09-15

3.  Gastric secretion in the isolated stomach of the guinea-pig.

Authors:  J Spencer
Journal:  J Physiol       Date:  1974-03       Impact factor: 5.182

Review 4.  Histamine and gastric secretion: a later look, 1955-1965.

Authors:  C F Code
Journal:  Fed Proc       Date:  1965 Nov-Dec

5.  Pharmacological analysis of muscarinic receptors coupled to oxyntic cell secretion in the mouse stomach.

Authors:  J W Black; N P Shankley
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

6.  Inhibition of acid secretion in dog by metiamide, a histamine antagonist acting on H2 receptors.

Authors:  M I Grossman; S J Konturek
Journal:  Gastroenterology       Date:  1974-04       Impact factor: 22.682

7.  Ultrastructural localisation of carbonic anhydrase in rat stomach parietal cells.

Authors:  S A Cross
Journal:  Histochemie       Date:  1970

8.  Histamine-stimulated hydrogen ion secretion by in vitro piglet gastric mucosa.

Authors:  J G Forte; T M Forte; T E Machen
Journal:  J Physiol       Date:  1975-01       Impact factor: 5.182

9.  Pharmacological analysis of the pentagastrin-tiotidine interaction in the mouse isolated stomach.

Authors:  J W Black; P Leff; N P Shankley
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

10.  Estimation of pKB values for histamine H2-receptor antagonists using an in vitro acid secretion assay.

Authors:  J A Angus; J W Black; M Stone
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

View more
  34 in total

1.  Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic action.

Authors:  Y J Liu; N P Shankley; N J Welsh; J W Black
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

Review 2.  The role of platelet activating factor in allergic respiratory disease.

Authors:  C P Page
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

3.  Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach.

Authors:  J W Black; N P Shankley
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

4.  Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays.

Authors:  S P Roberts; E A Harper; G F Watt; V P Gerskowitch; R A Hull; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

5.  Pharmacology: analysis and exploration.

Authors:  J W Black
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-26

6.  Stimulation by McN-A-343 and blockade by telenzepine of acid secretion in the mouse isolated stomach at histamine-liberating cells.

Authors:  W Kromer; E Baron; M Beinborn; M Eltze; W A Simon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

7.  Further analysis of anomalous pKB values for histamine H2-receptor antagonists on the mouse isolated stomach assay.

Authors:  J W Black; P Leff; N P Shankley
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

8.  Pharmacological analysis of the pentagastrin-tiotidine interaction in the mouse isolated stomach.

Authors:  J W Black; P Leff; N P Shankley
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

9.  2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-NAP)--a selective cholecystokinin CCKA-receptor antagonist.

Authors:  R A Hull; N P Shankley; E A Harper; V P Gerkowitch; J W Black
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

10.  Comparative study of the control of basal acid output from rodent isolated stomachs.

Authors:  N J Welsh; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.